Additionally, the donation of functional mitochondria from human MSCshBAK+MCL1 prevented macropore formation in the recipient SARS-CoV-2-infected or NSP4/ORF9b-expressing airway epithelial cells, which can be a potential therapeutic strategy for COVID-19. The gene discussed is MCL1; the disease is COVID-19.